3 new drugs to treat rheumatoid arthritis in uk
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
British scientists say three drugs that have been developed will offer new hope to thousands of people with rheumatoid arthritis in the UK could help many relieve pain and enable them to lead almost normal livesRheumatoid arthritis is caused by the immune system attacking the joint areaResearch has shown that the newly developed Mab Thera, Orencia and Tocilizumab can reduce the symptoms of rheumatoid arthritis and have a significant effect on joint pain, stiffness and swelling caused by rheumatoid arthritisAll three drugs work on the immune systemMerrow acts on B-cells of the immune systemDuring the trial, more than one-third of patients were able to reduce 50% of their symptomsOrencia acts on immune system T cells, and 40% of patients can also reduce symptoms by 50% if combined with methotrexateTocilizumab acts on cytokine leptin-6, which activates T cells, and although the drug has not yet been approved, clinical trials have shown it has a similar effect to two other drugsStudies have shown that all three drugs can alleviate the condition and alleviate the symptoms ofdisease, especially when treated in combination with the drug methotrexate used in general treatmentBut these three new drugs don't work for all patients, with about 30 to 40 percent of patients showing significant improvement, but some have serious side effectsCurrently, two new drugs, MabThera and Orencia, have been approved in the UK and Tocilizumab is subject to a period of clinical trialsNew drugs offer more opportunities to treat rheumatoid arthritis, scientists sayProfessor Joseph, the team leader, believes the treatment of rheumatoid arthritis has entered a new historical periodProfessor Paul, a British expert, said the drugs were effective and had a different effect than existing drugsThat means we have more options, especially for those who have a life-long disease of rheumatoid arthritis in their 20s , says Isa, chief executive of the National Rheumatoid Arthritis Association Traditional treatments for rheumatoid arthritis include nonsteroidal compounds, nonsteroidal anti-inflammatory drugs, glucocorticoid steroids, etc., but the efficacy is very limited
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.